Holen Sie sich die Stockscreener-App
17.07
2.72%
-0.4769
Schlusskurs vom Vortag:
$17.55
Offen:
$17.6
24-Stunden-Volumen:
11,987
Relative Volume:
0.93
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+0.71%
1M Leistung:
+3.71%
6M Leistung:
+33.99%
1J Leistung:
+94.31%
1-Tages-Spanne:
$16.92
$17.60
1-Wochen-Bereich:
$16.92
$17.81
52-Wochen-Spanne:
$7.14
$17.81
Advisorshares Psychedelics Etf Stock (PSIL) Company Profile
Firmenname
Advisorshares Psychedelics Etf
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie PSIL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PSIL
Advisorshares Psychedelics Etf
|
17.07 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
318.20 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
645.05 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
648.32 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
252.50 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
570.40 | 124.43B | 0 | 0 | 0 | 0.00 |
Advisorshares Psychedelics Etf Aktie (PSIL) Neueste Nachrichten
AdvisorShares Psychedelics ETF (NYSEARCA:PSIL) Shares Down 2.7% – Here’s Why - Defense World
AdvisorShares Psychedelics ETF (NYSEARCA:PSIL) Shares Down 2.7% – Should You Sell? - Defense World
This Psychedelics ETF Has Investors Going Crazy (In a Good Way) - ETF Database
What's Going On With Quantum Biopharma Stock Tuesday?Quantum BioPharma (NASDAQ:QNTM) - Benzinga
(PSIL) Proactive Strategies - news.stocktradersdaily.com
Don't Trip. These Psychedelic Stocks May Have Some Life in Them Yet - US News Money
(PSIL) Investment Analysis - news.stocktradersdaily.com
5 ETFs That Beat the Market in the First Half of 2025 - Zacks Investment Research
Psychedelics regain momentum in 2025 on political tailwinds, clinical wins | NASDAQ:ATAI, ETR:9VC - Proactive financial news
(PSIL) Technical Pivots with Risk Controls - news.stocktradersdaily.com
Ex-Gov't Foe Joins Trump, RFK Jr.'s HHS To Lead Psychedelics Policy: What It Means For Investors - Benzinga
Worst Thematic ETFs of 2021: How are they faring today? - Trackinsight
(PSIL) Trading Report - news.stocktradersdaily.com
Where are the Opportunities in (PSIL) - news.stocktradersdaily.com
The Zacks Analyst Blog Highlights SGDM, SLVP, SHLD, COPJ and PSIL - Zacks Investment Research
5 Sector ETFs That Have Outperformed the S&P 500 in Q1 - TradingView
AdvisorShares Psychedelics ETF (NYSEARCA:PSIL) Trading Down 0.2% – What’s Next? - Defense World
(PSIL) Investment Analysis and Advice - news.stocktradersdaily.com
Best Mushroom Stocks: Top Picks, Pros and Cons - timothysykes.com
Novamind Announces Inclusion in NYSE Listed AdvisorShares Psychedelics ETF - ACCESS Newswire
TheStreet Pro - TheStreet
5 Best-Performing Sector ETFs Halfway Through Q1 - MSN
Psychedelic Funding, Public Markets, and M&A in 2024 - Psychedelic Alpha
Psychedelic ETF PSIL Is 2025's Best-Performing ETF - ETF.com
High-Momentum ETFs Leading the Market This Year - FinancialContent
Shares Soar as GH Research Unveils Promising Drug Trial - Value The Markets
5 Best-Performing Sector ETFs of Volatile January - Yahoo.co
5 Best-Performing ETFs of January - Nasdaq
Under-the-Radar Opportunities in ETFs - ETF Trends
ETF Prime: Islam Shares 2025's Top Trends and ETFs - ETF Trends
Objective long/short (PSIL) Report - Stock Traders Daily
5 Best-Performing Sector ETFs of Q4 - Nasdaq
Why Is Penny Stock Clearmind Gaining Today? - Benzinga
ADVISORSHARES PSYCHEDELICS ETF To Go Ex-Dividend On December 23rd, 2024 With 0.05477 USD Dividend Per Share - 富途牛牛
EMIF, PSIL: 2 ETFs with Over 20% Upside Potential, According to Analysts - TipRanks
Vaccine Stocks Slide, Psychedelic Stocks Surge After RFK Jr. HHS Nomination - Barchart.com
No Trippin’: Trump Trade Pushes PSIL, VCAR Higher - ETF.com
5 Best-Performing ETFs of October - Nasdaq
DRUG Enhances Buzz for Psilocybin, Psychedelic ETFs - ETF.com
ADVISORSHARES PSYCHEDELICS ETF To Go Ex-Dividend On September 23rd, 2024 With 0.1087 USD Dividend Per Share - 富途牛牛
Reverse split for AdvisorShares Psychedelic ETF starts today - Crain's Chicago Business
ADVISORSHARES PSYCHEDELICS ETF To Carry Out 1-for-10 Reverse Stock Split On September 10th, 2024 - 富途牛牛
AdvisorShares Announces Reverse Split of ETF - Stock Titan
Best Psychedelic ETFs - Benzinga
Losing Ones Sense of Self – How Psilocybin Breakthroughs Could Spark Fresh Investments - Securities.io
Top and Flop ETFs of the First Half - Yahoo Finance
Best and Worst ETF Zones of Q2 - Nasdaq
LSD, Ecstasy Lure Traders Betting On 'Psychedelic Renaissance' - FA Mag
Psychedelic Funding & Public Markets in 2023 - Psychedelic Alpha
Psychedelics Are Going Mainstream. Investing in Them Hasn’t.WSJ - The Wall Street Journal
Psyched: Steve Cohen Goes Big On Cybin, Fed Intervention On Psilocybin, Ketamine Insurance And More - Benzinga
Finanzdaten der Advisorshares Psychedelics Etf-Aktie (PSIL)
Es liegen keine Finanzdaten für Advisorshares Psychedelics Etf (PSIL) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.04%
1.16%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):